Kolexia
Bodere Francoise
Médecine nucléaire
Hôpital Hôtel-Dieu Nantes
Nantes, France
291 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Myélome multiple Lymphomes Tumeurs de la prostate Métastase tumorale Carcinomes Tumeurs du sein Lymphome B Tumeurs de la thyroïde Lymphome B diffus à grandes cellules

Industries

Sanofi
13 collaboration(s)
Dernière en 2023
Advanced Accelerator Applications
13 collaboration(s)
Dernière en 2023
Janssen
7 collaboration(s)
Dernière en 2021
Sociétés étrangères du groupe AAA
3 collaboration(s)
Dernière en 2022

Dernières activités

LyMa101: Phase II Study to Evaluate the Efficacy of Upfront Obinutuzumab in Mantle Cell Lymphoma Patients Treated by DHAP Followed by Autologous Transplantation Plus Obinutuzumab Maintenance Then MRD Driven Maintenance
Essai Clinique (The Lymphoma Academic Research Organisation)   13 mars 2024
Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence.
European journal of nuclear medicine and molecular imaging   19 décembre 2023
The contest between internal and external-beam dosimetry: The Zeno’s paradox of Achilles and the tortoise
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)   02 décembre 2023
Prognostic Value of F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   09 novembre 2023
Low Tmtv Influences Response and Outcomes in R/R DLBCL 3L+ Patients Treated with CAR-T Cells : First Results of FDG-PET/CT Analysis in the French Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Étude prospective TEP/TDM au 68GA-PSMA chez des patients en récidive occulte du cancer de la prostate (Rebioloc) : impact sur la décision thérapeutique et bénéfice à long terme
117e congrès français d'urologie   01 novembre 2023
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
Scientific reports   24 octobre 2023
Validation of the ΔSUV for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   21 septembre 2023
How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.
European journal of nuclear medicine and molecular imaging   09 septembre 2023
New Developments in Myeloma Treatment and Response Assessment.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   17 août 2023